UNC Lineberger launches 44-county study of breast cancer in black women

October 30, 2008

CHAPEL HILL - A new study seeking to improve scientists' understanding of breast cancer, including why the disease's fatality rate is higher in African-American women, is getting underway in 44 counties in North Carolina.

The project, named after the late Jeanne Hopkins Lucas, a North Carolina state senator who died of breast cancer last year, is being run by the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill.

The research is an extension of the Carolina Breast Cancer Study, one of the largest breast cancer databases in the United States.

Potential participants will be identified from among women living in the 44 North Carolina counties, as participating hospitals report newly diagnosed breast cancer cases to the North Carolina Central Cancer Registry. Using a scientifically selected study sample, UNC researchers will contact the physician of record prior to contacting the patient about the study.

Robert Millikan, D.V.M., Ph.D., Barbara Sorensen Hulka Distinguished Professor of Epidemiology in the UNC Gillings School of Global Public Health, is the study's principal investigator. Mary Beth Bell, project manager of the Carolina Breast Cancer Study, is coordinating the project team, which includes nurse interviewers, recruitment specialists, outreach coordinators and others. The study is supported by the University Cancer Research Fund.

"Black women under the age of 50 have a high mortality rate from breast cancer, almost twice that of younger white women," said Millikan. "We will address this pressing health disparity by enlarging upon the Carolina Breast Cancer Study, which enrolled over 2,300 women with breast cancer and 2,000 control subjects between 1993 and 2001."

One of the Lucas study's primary aims is to investigate subtypes of breast cancer, continuing discoveries made by the Carolina Breast Cancer Study. Data from the existing study were key to a 2006 finding by a UNC Lineberger team that included Millikan, molecular biologist Charles Perou, Ph.D., associate professor in the departments of genetics and of pathology and laboratory medicine in the School of Medicine, and breast cancer specialist Lisa Carey, M.D., associate professor of medicine in the School of Medicine and medical director of the UNC Breast Center. They found that premenopausal black breast cancer patients have the highest prevalence of a subtype of breast cancer called "basal like" cancer.

"Between now and 2012 we will enroll an additional 1,000 black women with newly diagnosed cases of invasive breast cancer - half under the age of 50 and half aged 50 and older - and a similar number and distribution of white women with breast cancer," Millikan said. "The Lucas Study will more than double the number of black breast cancer patients in the original study. We will also follow the 2,000 women for two years following diagnosis to examine disparities in treatment and access to care."

Millikan said the help of doctors and hospitals would be key to the study's success. "Since this study is not one for which women can volunteer, the help of physicians is vital to us as we reach out to recruit participants in these counties," he said. For the study results to be unbiased, women must be selected through a scientific randomization process, and an equal number of black women and white women will be recruited over a four-year period.

No treatment of any kind will be given as part of the study. Participants will be interviewed in their homes by trained nurses regarding breast cancer risk factors, and a DNA blood sample will be taken to help determine factors that women with breast cancer have in common. Researchers will also request patients' permission to access their medical records relating to breast cancer diagnosis and treatment.

An advocacy board consisting of breast cancer survivors and others interested in various aspects of breast cancer research has been established to guide the study design and the entire study process.

"We are committed to the success of this study as we have evidenced the devastating impact of breast cancer in young African American women," said Valarie Worthy, president of the Sisters Network Triangle NC.
-end-
Participating counties are: Alamance, Beaufort, Bertie, Bladen, Brunswick, Cabarrus, Chatham, Columbus, Craven, Cumberland, Davidson, Davie, Duplin, Durham, Edgecombe, Forsyth, Franklin, Granville, Greene, Guilford, Harnett, Iredell, Johnston, Jones, Lee, Lenoir, Martin, Mecklenburg, Moore, Nash, New Hanover, Onslow, Orange, Pamlico, Pender, Pitt, Randolph, Rowan, Sampson, Tyrrell, Wake, Washington, Wayne and Wilson.

NOTE: Millikan can be contacted at (919) 966-7437 or millikan@email.unc.edu.

Lineberger Comprehensive Cancer Center contact: Dianne Shaw, (919) 966-5905, dgs@med.unc.edu Gillings School of Global Public Health contact: Ramona DuBose, (919) 966-7467, ramona_dubose@unc.edu

News Services contact: Patric Lane, (919) 962-8596, patric_lane@unc.edu

University of North Carolina at Chapel Hill

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.